Brokers name 3 ASX shares to buy today

Sirtex Medical Limited (ASX:SRX) could be a bargain if it continues to perform.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

They often need to be taken with a grain of salt, but broker recommendations can also be a good place to start generating some new investment ideas.

One company that appears to be on UBS's radar is liver cancer treatment business Sirtex Medical Limited (ASX: SRX), which provided an updated guidance on sales of its radioactive microspheres treatment yesterday. The company said it expects sales to rise 16.4% over the prior corresponding period, putting it at the upper end of the target range of 15% to 17% provided last month.

The shares did trade for as much as $41.33 late last year, but have since tracked back down to $27.88 as at yesterday's close. UBS thinks it can get back to that high and then some, putting a $44 price target on the shares.

Compared to shares of Sirtex, Capilano Honey Ltd (ASX: CZZ) has enjoyed a more consistent run in 2016 and did briefly peak above $23 a share in May, but shares now fetch $20.22. According to Dow Jones Newswires, Canaccord Genuity has raised its target price on the shares by 4.5% to $22.50, while Morgans recently raised its own target by 6% to $23.10.

Resources giant BHP Billiton Limited (ASX: BHP) also got the nod from Citi which, according to Dow Jones Newswires, has increased its target price by 7.7% to $21.00 per share. That's up from today's price of $19.60.

BHP Billiton shares experienced a sharp fall earlier in the year as a result of crashing oil and iron ore prices, but have since recovered much of their losses. Both resources have rebounded strongly (although they remain well below their highs from recent years), with Citi apparently confident that investors could be in for further gains in the near future.

Of the three businesses mentioned, Sirtex Medical is the most attractive option today, in my opinion. Considering the nature of the biopharmaceutical industry, it is by no means a risk-free bet, but it could prove reasonably priced at its current level if it can maintain double-digit growth over the coming years.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »